Back to Search
IRA BIRD, MD
MD
Surgery Physician
NPI: 1801843099IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
016946(ME)
CMS Specialties
PrimaryGENERAL SURGERY
Education
UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE
Class of 1999
Research & Publications (20)
Generation of high-sensitivity antisense cDNA probes by asymmetric PCR.
PMID 16028686·Methods Mol Med·2005
8-other
Expression of AT1-R in marmoset whole adrenal glands and adrenocortical cells in culture.
PMID 15666821·Endocr Res·2004
7-preclinical
Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function.
PMID 12529278·Am J Physiol Regul Integr Comp Physiol·2003
6-review
Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells.
PMID 10698187·Endocrinology·2000
7-preclinical
The developmental increase in adrenocortical 17,20-lyase activity (biochemical adrenarche) is driven primarily by increasing cytochrome b5 in neonatal rhesus macaques.
PMID 19036885·Endocrinology·2009
7-preclinical
Antenatal betamethasone depresses maternal and fetal aldosterone levels.
PMID 18997118·Reprod Sci·2009
7-preclinical
Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.
PMID 18816248·Biochem J·2009
7-preclinical
Plasticity of the zona reticularis in the adult marmoset adrenal cortex: voyages of discovery in the New World.
PMID 19474057·J Endocrinol·2009
6-review
Nonhuman primates as models for human adrenal androgen production: function and dysfunction.
PMID 18683055·Rev Endocr Metab Disord·2009
6-review
Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome.
PMID 18493139·Endocr Dev·2008
6-review
Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR.
PMID 17684489·Oncogene·2008
8-other
Gender and gonadal status differences in zona reticularis expression in marmoset monkey adrenals: Cytochrome b5 localization with respect to cytochrome P450 17,20-lyase activity.
PMID 17222503·Mol Cell Endocrinol·2007
7-preclinical
Pregnancy-enhanced Ca2+ responses to ATP in uterine artery endothelial cells is due to greater capacitative Ca2+ entry rather than altered receptor coupling.
PMID 16899570·J Endocrinol·2006
7-preclinical
Inhibition of MEK/ERK1/2 signalling alters endothelial nitric oxide synthase activity in an agonist-dependent manner.
PMID 16716148·Biochem J·2006
7-preclinical
Dissociation of endothelial nitric oxide synthase phosphorylation and activity in uterine artery endothelial cells.
PMID 16272197·Am J Physiol Heart Circ Physiol·2006
7-preclinical
Pregnancy-enhanced endothelial nitric oxide synthase (eNOS) activation in uterine artery endothelial cells shows altered sensitivity to Ca2+, U0126, and wortmannin but not LY294002--evidence that pregnancy adaptation of eNOS activation occurs at multiple levels of cell signaling.
PMID 16455784·Endocrinology·2006
7-preclinical
NMR assignment of the mTOR domain responsible for rapamycin binding.
PMID 16456707·J Biomol NMR·2006
8-other
Pregnancy-enhanced store-operated Ca2+ channel function in uterine artery endothelial cells is associated with enhanced agonist-specific transient receptor potential channel 3-inositol 1,4,5-trisphosphate receptor 2 interaction.
PMID 16899571·J Endocrinol·2006
7-preclinical
Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome.
PMID 16174719·J Clin Endocrinol Metab·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 121 MEDICAL CENTER DRIVE, SUITE 2550
BRUNSWICK, ME 04011 - Phone
- (207) 373-1707
Quick Facts
- NPI
- 1801843099
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile